| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.23 | 0.1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |